Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) is a medical technology company specializing in artificial intelligence-powered wound assessment, best known for its DeepView system designed to aid clinicians in evaluating burn and trauma injuries. The company entered public markets in 2023 through a SPAC business combination and remains an active reporting issuer, as reflected by an 8-K disclosure filed with the SEC on September 15, 2023. Spectral AI operates in the healthcare technology and AI diagnostics sector, addressing a clinical need for objective, non-invasive wound severity prediction. For complete SPAC deal histories, sponsor profiles, and filing data on MDAI and thousands of other transactions, sign up for full access at SpacDesk.